Simvastatin Therapy Increased miR-150-5p Expression in the Patients with Type 2 Diabetes and COVID-19.

Mandana AmeliMojarad,Melika AmeliMojarad, Alireza Pourmadian

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology（2022）

引用 0|浏览1

暂无评分

摘要

Simvastatin as an anti-inflammatory agent can modulate miRNAs expression; it can be suggested as an adjunct therapy especially for T2DM patients with COVID-19. Further studies may help us for developing better treatments about therapeutic manipulation of miRNAs in vivo.

查看译文

关键词

miR-150-5p, COVID-19, T2DM, Statin, Simvastatin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Simvastatin Therapy Increased miR-150-5p Expression in the Patients with Type 2 Diabetes and COVID-19.

Simvastatin Therapy Increased miR-150-5p Expression in the Patients with Type 2 Diabetes and COVID-19.